Recent advances in the management and understanding of macular degeneration

Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadorani, Sepehr, Singer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399962/
https://www.ncbi.nlm.nih.gov/pubmed/28491291
http://dx.doi.org/10.12688/f1000research.10998.1
_version_ 1783230738932432896
author Bahadorani, Sepehr
Singer, Michael
author_facet Bahadorani, Sepehr
Singer, Michael
author_sort Bahadorani, Sepehr
collection PubMed
description Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD.
format Online
Article
Text
id pubmed-5399962
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-53999622017-05-09 Recent advances in the management and understanding of macular degeneration Bahadorani, Sepehr Singer, Michael F1000Res Review Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD. F1000Research 2017-04-20 /pmc/articles/PMC5399962/ /pubmed/28491291 http://dx.doi.org/10.12688/f1000research.10998.1 Text en Copyright: © 2017 Bahadorani S and Singer M http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Bahadorani, Sepehr
Singer, Michael
Recent advances in the management and understanding of macular degeneration
title Recent advances in the management and understanding of macular degeneration
title_full Recent advances in the management and understanding of macular degeneration
title_fullStr Recent advances in the management and understanding of macular degeneration
title_full_unstemmed Recent advances in the management and understanding of macular degeneration
title_short Recent advances in the management and understanding of macular degeneration
title_sort recent advances in the management and understanding of macular degeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399962/
https://www.ncbi.nlm.nih.gov/pubmed/28491291
http://dx.doi.org/10.12688/f1000research.10998.1
work_keys_str_mv AT bahadoranisepehr recentadvancesinthemanagementandunderstandingofmaculardegeneration
AT singermichael recentadvancesinthemanagementandunderstandingofmaculardegeneration

Ejemplares similares